Matthew Hill
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthew Hill
Earlier roles on record: CFO at PDS Biotechnology Corp (PDSB) until December 1, 2023. PDS Biotechnology Corp reported in an 8-K filed November 28, 2023 that Matthew Hill resigned as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective December 1, 2023. Matthew Hill has spoken on 7 earnings calls across 1 company, most recently for PDS Biotechnology Corp on November 14, 2023.
“On November 21, 2023, Matthew Hill submitted his resignation, effective December 1, 2023, as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of PDS Biotechnology Corporation (the "Company") in order to pursue other professional endeavors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-12-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.